Adaptive Biotechnologies to Present at the 39th Annual J.P. Morgan Healthcare Conference
31 December 2020 - 8:30AM
Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”)
(Nasdaq: ADPT), a commercial stage biotechnology company that
aims to translate the genetics of the adaptive immune system into
clinical products to diagnose and treat disease, today announced it
will be participating in the upcoming 39th Annual J.P. Morgan
Healthcare Conference.
Adaptive Biotechnologies’ management is
scheduled to present on Monday, January 11th at 1:30 p.m. Pacific
Time / 4:30 p.m. Eastern Time. Interested parties may access a live
and archived webcast of the presentation on the “Investors” section
of the company website at: www.adaptivebiotech.com.
About Adaptive
BiotechnologiesAdaptive Biotechnologies is a
commercial-stage biotechnology company focused on harnessing the
inherent biology of the adaptive immune system to transform the
diagnosis and treatment of disease. We believe the adaptive immune
system is nature’s most finely tuned diagnostic and therapeutic for
most diseases, but the inability to decode it has prevented the
medical community from fully leveraging its capabilities. Our
proprietary immune medicine platform reveals and translates the
massive genetics of the adaptive immune system with scale,
precision and speed to develop products in life sciences research,
clinical diagnostics and drug discovery. We have two commercial
products and a robust clinical pipeline to diagnose, monitor and
enable the treatment of diseases such as cancer, autoimmune
conditions and infectious diseases. Our goal is to develop and
commercialize immune-driven clinical products tailored to each
individual patient.
ADAPTIVE INVESTORSKarina Calzadilla, Vice
President, Investor Relations201-396-1687Carrie
Mendivil, Gilmartin Groupinvestors@adaptivebiotech.com
ADAPTIVE MEDIABeth
Keshishian917-912-7195media@adaptivebiotech.com
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Apr 2024 to May 2024
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From May 2023 to May 2024